Treace Medical Concepts disclosed a purchase in an SEC filing, and Truist Financial increased its target price for the company.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Treace Medical Concepts disclosed a purchase in an SEC filing, and Truist Financial increased its target price for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Truist Financial increased its price objective while First Citizens BancShares disclosed sales with the SEC.
- Atlassian filed an SEC disclosure while Raymond James Financial and Truist Financial issued new price objectives and target lifts.
- Financial institutions, including Wells Fargo and Bank of America, issued rating updates and filed reports regarding institutional stake reductions with the SEC.
- Institutional filings and research reports were provided by entities involving O'Reilly Automotive and Truist Financial to the SEC.
- Analyst firms set price targets and issued price objectives for Applied Materials, with company filings reported to the SEC.